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Executive Summary 
There are over two million patients in the United States that have cardiovascular 
implantable electronic devices (CIEDs).  In 2017, the Heart Rhythm Society (HRS) provided a 
consensus statement with guidelines and recommendations for device management of patients 
with magnetic resonance (MR) conditional as well as MR non-conditional CIEDs (Indik et al. 
2017).  In January 2018, the Centers for Medicare and Medicaid Services (CMS) proposed that a 
qualified physician, nurse practitioner (NP), or physician assistant (PA) with expertise in 
implanted permanent pacemakers (PM), implantable cardioverter defibrillator (ICD), cardiac 
resynchronization therapy pacemakers (CRT-P), or cardiac resynchronization therapy 
defibrillators (CRT-D) must directly supervise patients with CIEDs during magnetic resonance 
imaging (MRI).  
Manuscript 
A comprehensive review of literature was conducted using search terms.  Search terms 
utilized were magnetic resonance imaging, cardiac implantable electronic devices, MRI, MRI 
safety, MRI adverse effects, CIED, CIED interference, pacemaker, and implantable cardioverter 
defibrillator.  The following databases were accessed to search for relevant literature: Cochrane, 
CINAHL, PubMed, Evidence-Based Journals, Scopus, Medscape, Heart Rhythm Society, and 
American Heart Association.  The search yielded 30 articles.  The final yield was 12 articles. 
Articles were selected for inclusion if they addressed CIEDs, MRIs, safety, safety concerns, and 
written in the English language.  Articles were excluded if they were more than ten years old and 
focused only on specific manufacturers.   
Articles were critically appraised with the Johns Hopkins Nursing Evidence-Based 
Practice Non-Research and Research Evidence Appraisal Tools (Dang & Dearholt, 2018). These 
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tools provide a concise appraisal of the level and quality of the evidence.  Articles initially 
considered were utilized to guide the literature review and selected studies.  Articles were chosen 
based on the type of study as well as the number and type of CIEDs reviewed.  The twelve 
articles selected for inclusion were prospective, single non-randomized studies, multi-center 
cohort studies, a retrospective study, prospective study, randomized control trials, a meta-
analysis and systemic review, technical report, abstract, and clinical review. 
Prospective, Single Non-Randomized Studies 
Two of the nine studies included prospective, single non-randomized studies by Nazarian 
et al. (2017) and Bailey et al. (2016).  Both studies reviewed CIED interrogation results before 
and after the MRI with utilization of a standardized device management protocol.  Device 
interrogation with lead comparison was performed at enrollment, pre- and post-MRI scan, one-
month post-MRI, and three-month post-MRI. Both studies compared the effects of thoracic and 
non-thoracic MRI on CIEDs.  The results of these studies were consistent with other previously 
published reports that demonstrated no long-term clinically significant adverse events.  Bailey et 
al. (2016) had a sample size of two-hundred forty-five patients and Nazarian et al. (2017) had 
one thousand five hundred nine patients.  Limitations included small sample sizes and low 
number of cardiac MRIs but demonstrated MRI safety of PMs and ICDs.  
Prospective, Multicenter Cohort Studies  
Two prospective, multicenter cohort studies analyzed CIED interrogation results before 
and after the MRI with the utilization of a standardized protocol.  All studies were performed in a 
1.5 tesla (T) MRI scanner.  The prospective, multicenter study by Jung, Sebastian, and Zvereva 
(2015) identified the prospective adverse event rate and parameter changes in non-MRI CIEDs 
using a device registry.  Russo et al. (2017) analyzed PM and ICD data and confirmed the safety 
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of non-MRI conditional CIEDs that underwent clinically indicated non-thoracic MRI at 1.5T.  
Device or lead failure did not occur in both studies but was not predictive of findings with testing 
at higher magnetic strength greater than 1.5T.   
Retrospective and Prospective Cohort Study 
The only retrospective cohort study by Dandamudi et al. (2016) reviewed the device 
assessment reports in the electronic medical records of patients with CIEDs before and after the 
MRI with a CIED safety protocol.  When a comprehensive CIED MRI protocol is followed, the 
risk of performing 1.5T MRI with the device in the isocenter including pacemaker dependent 
patients is low.   
One prospective cohort study by Yadava et al. (2017) reviewed 277 patients who 
underwent 293 scans.  The CIEDs included 170 PMs and 71 ICDs.  Devices were interrogated 
before and after the MRI with the use of a standardized protocol.  The study demonstrated no 
changes in device settings during an MRI.  Long-term follow-up device assessment confirmed no 
adverse effects from 1.5T MRI.   
Randomized Control Trials 
Two randomized control trials (RCT) analyzed CIEDs before, during, and after the MRI 
with the use of an MRI scan protocol.  The study by Shenthar et al. (2015), evaluated MRI safety 
without positioning restrictions in patients with MR conditional PM with non-MR conditional 
leads.  Two hundred sixty-six patients were sampled with a two to one ratio to the MRI group or 
control group.  There were no related complications immediately and at one-month post-MRI.  
The second RCT by Wilkoff et al. (2011) evaluated PM performance and pacing capture 
threshold nine to twelve weeks prior to the MRI, during the MRI, and immediately after the 
MRI.  Four hundred sixty-four patients were randomized to undergo an MRI scan between nine 
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to twelve weeks post-CIED implantation.  Patients were monitored for arrhythmias, symptoms, 
and PM system function during fourteen non-clinically indicated brain and lumbar MRI 
sequences.  It was found that no MRI related complications occurred during or after the MRI. 
Meta-analysis and Systemic Review 
One meta-analysis and systematic review performed by Shah et al. (2018) utilized a 
random effects model for meta-analysis of continuous variables including device lead parameters 
such as capture threshold, sensing, and impedance; high-voltage ICD lead impedance, and 
battery voltage change.  Safety outcomes were evaluated with descriptive analysis.  Indexed 
articles from PubMed were queried between the years 1990-2017.  The search yielded one 
thousand three hundred twenty-four records to review.  Seventy studies were included for the 
systematic review, and five thousand ninety-nine patients were identified.  The brain or cervical 
spine was imaged the most and thoracic imaging was completed in seven hundred seventy-three 
patients.  The meta-analysis cohort included thirty-one studies.  This analysis summarized the 
safety profile of five thousand nine-hundred eight MRI studies in five thousand ninety-nine 
patients with non-MRI conditional CIEDs in a span of twenty-five years.  There were no 
reported deaths and three total lead failures.  There were no relevant changes in lead, battery, or 
pulse generator performance.  The observed changes were small, and inter-study variance was 
low.  The findings suggest the need for ongoing monitoring.   
Technical report/Clinical review/Abstract 
The technical report by Viera, Lazoura, Nicol, Rubens, and Padley (2013) analyzed data 
from a multicenter device registry.  Devices were interrogated before and after an MRI with the 
use of a standardized protocol.  The report confirmed the need for utilization of a comprehensive 
safety protocol and substantiated the development of new generation MRI conditional CIEDs.   
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The only clinical review by Nordbeck, Ertl, and Ritter (2015) provided a better 
understanding of the structures responsible for life-threatening complications as well as technical 
advances supporting the safety of MRIs for CIEDs.  Clinical trials were reviewed over the last 
twenty years, including fourteen PM and thirteen ICD studies.  The studies assessed the outcome 
in 1.5T scanners and reported there were no adverse events.  
The single abstract found in the literature review demonstrated CIED safety during an 
MRI with appropriate monitoring and application of a safety protocol.  It provided an overview 
of available data related to CIEDs and MRIs and attempted to offer up-to-date and a clinically 
useful summary for practicing cardiologists.   
Conclusion 
In conclusion, literature reviewed between 2011 and 2018 showed non-conditional 
CIEDs undergoing 1.5T MRI were evaluated pre, intra, and post-MRIs.  A CIED safety protocol 
was utilized in most studies.  Many of the studies reported CIED reprogramming before and after 
the MRI.  There were minimal to no MRI related complications or adverse effects.   
Findings from all the studies support the safety of the MRI for patients with conditional 
as well as non-conditional CIEDs at the magnetic strength of 1.5T and validate the 2017 HRS 
consensus statement demonstrated in the evidence table (Appendix A).  MRIs can be performed 
with appropriate monitoring and the utilization of a safety protocol.  More research is needed to 
evaluate the safety of MRIs at higher magnetic strength, greater than 1.5T.  Observational studies 
with larger sample sizes and involvement of multi-centers should also be considered.  With the 
evidence supporting the safety of MRIs for all CIEDs and incorporating the recent CMS 
guidelines, healthcare organizations must take the opportunity to evaluate their CIED 
management capabilities to comply with current staffing recommendations. 
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Appendix A – Evaluation Table 
 
 
Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal: 
Worth to 
Practice
Russo, R.R., 
Costa, H.S., 
Silva, P.D., 
Anderson, J.L., 
Arshad, A., 
Biederman, 
R.W.W., … 
Wolff, S.D. 
(2017). 
Assessing the 
risks 
associated with 
MRI in patients 
with a 
pacemaker or 
defibrillator. 
New England 
Journal of 
Medicine, 
376(8), 755-764.
None Prospective, 
multicenter 
study
N= 1500        1000 
cases in which 
patients had a 
pacemaker and in 
500 cases in 
which patients 
had an ICD
Devices were 
interrogated 
before and after 
MRI with the 
use of a 
standardized 
protocol and 
were 
appropriately 
reprogrammed 
before the 
scanning.
All studies 
were performed 
in a 1.5-tesla 
MRI
Data were 
analyzed 
separately for 
the pacemaker 
and ICD 
cohorts with 
the use of R 
statistical
software, 
version 
3.2.3.16.  The 
Wilson score 
method without
continuity 
correction was 
used to 
calculate 95%
confidence 
intervals for 
single 
proportions for
primary end-
point events.
Device or lead 
failure did not 
occur in any 
patient with a 
non–MRI 
conditional 
pacemaker or 
ICD who 
underwent 
clinically 
indicated 
nonthoracic
MRI at 1.5 
tesla
Strengths:    
Data from both 
pacemakers and 
ICDs.  
Multicenter 
study.  
Limitations:   
The results are 
not predictive of 
findings with all 
device lead 
combinations or 
higher MRI field 
strengths.                                                                                                          
Critical 
Appraisal Tool 
& Rating:          
John Hopkins 
Research 
Evidence 
Appraisal Tool , 
III A/B.      
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:        
Worth to Practice
Yadava, M., 
Nugent, M., 
Krebsbach, A., 
Minnier, J., Jessel, 
P., & Henrikson, 
C.A. (2017). 
Magnetic 
resonance imaging 
in patients with 
cardiac implantable 
electronic devices. 
Journal of 
Interventional 
Cardiac 
Electrophysiology
,50, 95-104.
None Prospective 
Cohort Study
N = 277 patients 
underwent 293 
scans.  The 
devices included 
170 pacemakers 
and 71 ICDs
Devices were 
interrogated 
before and after 
MRI with the 
use of a 
standardized 
protocol and 
were 
appropriately 
reprogrammed 
before the 
scanning.
All studies were 
performed in a 1.5-
tesla MRI scanner.  
Statistical analysis 
was performed with 
the R programming
language.  The 
comparison of 
normally 
distributed
variables between 
device groups was 
performed with two 
sample
t tests and non-
normally 
distributed 
variables were 
compared
with two-sample  
Wilcoxon tests
Patients with permanent 
pacemakers (PPM) or 
implantable cardioverter-
defibrillator (ICD) and a 
clinical indication for an 
MRI were considered.  
Exclusion criteria included 
newly implanted devices 
(<4 weeks), PPMs 
manufactured before 1996 
and ICDs before 2000, 
epicardial and abandoned 
leads, and pacemaker 
dependent ICD patients. 
Pacemaker dependent 
patients were programmed 
to asynchronous pacing.  
Tachycardia detection and 
therapies were disabled for 
ICDs.   Devices were 
interrogated pre and post-
scan and at follow up 1-6 
weeks later.  Defibrillation 
threshold testing (DFT) 
was not completed post-
scan.  Patients were 
followed to monitor device 
therapies.  
The devices included 
170 pacemakers and 71 
ICDs. Thirteen scans 
were aborted due to 
subjective complaints 
or artifact on imaging.  
Post-scan and follow-
up interrogations 
showed no changes in 
device settings 
requiring 
reprogramming or 
revision.  Long-term 
follow-up demonstrated 
that nine ICD patients 
had  appropriate device 
shocks and one had 
four inappropriate 
shocks for atrial 
fibrillation.  
Strengths:          
Data from both 
pacemakers and 
ICDs.      
Limitations: Follow-
up data was not 
available for some 
of their patients due 
to the large number 
of them being 
referred from 
outside physicians.   
It was difficult to 
accurately obtain 
information about 
device parameters.  
Device malfunction 
could not be ruled 
out in those 
patients who were 
lost to follow-up.     
Critical Appraisal 
Tool & Rating:  
John Hopkins 
Research Evidence 
Appraisal Tool,  III 
A/B.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:          
Worth to Practice
Dandamudi, S., 
Collins, J.D., 
Carr, J.C., 
Mongkolwat, 
P., Rahsepar, 
A.A., Tomson, 
T.T., … Knight, 
B.P. (2016). The 
safety of 
cardiac and 
thoracic 
magnetic 
resonance 
imaging in 
patients with 
cardiac 
implantable 
electronic 
devices. 
Academic 
Radiology , 
23 (12), 1485-
1505.
None Retrospective 
cohort study
N = 58 patients 
underwent 51 
cardiac and 11 
thoracic spine 
MRI exams. 
The cardiac device 
information was 
acquired from 
interrogation
reports in the 
electronic medical 
record, which 
included a 
mandatory
device assessment 
pre- and post-MRI 
scanning, per the 
prespecified CIED 
safety protocol.
Devices were 
interrogated before 
and after imaging 
with reprogramming 
to asynchronous 
pacing in pacemaker 
dependent
patients. The clinical 
interpretability of the 
MRI and peak and 
average specific 
absorption
rates (SARs, W/kg) 
achieved were 
determined.
Twenty-nine patients had a 
pacemakers and 29 patients 
had ICDs.  Ten patients were 
pacemaker dependent.  Fifty-
one patients had non-MRI 
conditional devices.   There 
were no significant changes in 
atrial and ventricular sensing 
impedance, and threshold 
measurements.  There were no 
episodes of device mode 
changes, arrhythmias, 
therapies delivered, electrical 
reset, or battery depletion. 
One study was discontinued 
because the patient 
experienced chest pain (not 
related to the exam).  
When a comprehen-
sive CIED MRI safety 
protocol is followed, 
the risk of performing 
1.5T magnetic 
resonance studies 
with the device in the 
magnet isocenter, 
including pacemaker 
dependent patients is 
low.
Strengths:             
Data from both 
pacemakers and ICDs. 
Utilization of thoracic 
scans.       
Limitations:           
The study had a small 
sample size in 
addition to the small 
number of patients 
with repeat MRI 
exams.The 
retrospective nature 
of the study  did not 
allow for control of all 
confounding 
variables,  did not 
allow for control of all 
confounding 
variables.                   
Critical Appraisal 
Tool & Rating:                    
John Hopkins 
Research Evidence 
Appraisal Tool , III 
A/B.
EXPANDING MAGNETIC RESONANCE IMAGING MANUSCRIPT 14 
 
 
 
 
Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:      
Worth to Practice
Jung,W., Sebastian, 
J., Zvereva, V. 
(2015). MRI and 
implantable cardiac 
electronic devices. 
Current Opinion in 
Cardiology , 30(1), 
65-73.
None Prospective 
Study, 
Multicenter
N= 34 
prospective 
studies from1998-
2014.  
The MagnaSafe 
registry determined
prospectively the 
adverse event rate 
and device 
parameter
changes in patients 
with non-MRI-
conditional cardiac 
devices 
(pacemakers or 
ICDs) implanted 
after
2001, undergoing 
clinically indicated 
nonthoracic
MRI at 1.5 T.
Data from 
MagnaSafe 
registry. 
Data was extracted 
from 1.5T MRI 
scans.  
Development of 
MRI conditional 
devices has 
improved the risk 
benefit.  Risks 
have been low; 
however, minor 
risks have 
significant effects.
Strengths:              
Data from both 
pacemakers and 
ICDs. Studies from 
1998-2014.  Data 
extracted from all 
studies.   
Limitations:      
Data from all 
studies only used 
1.5T magnetic field.  
Should test at 
higher magnetic 
strength.        
Critical Appraisal 
Tool & Rating: 
John Hopkins 
Research Evidence 
Appraisal Tool , III 
A/B.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:     
Worth to Practice
Viera, M.S., 
Lazoura, O., 
Nicol, E., 
Rubens, M. & 
Padley, S. (2013). 
MRI in patients 
with 
cardiovascular 
implantable 
electronic 
devices. 
Clinical 
Radiology , 
68(2013), 928-
934. 
None Technical 
Report
Interim analysis 
of the multicentre 
MagnaSafe 
Registry
Devices were 
interrogated 
before and after 
MRI with the use 
of a standardized 
protocol and 
were 
appropriately 
reprogrammed 
before the 
scanning.
Analysis of 
the multicentre 
MagnaSafe 
Registry
Risks were 
identified, need for 
comprehensive 
safety protocol. 
New generation of MRI 
conditional pacemakers 
developed.  Higher risk 
with ICD and CRT 
devices.  
Strengths: 
Identification of 
risks, need for 
safety protocols. 
Limitations:     
Data from all 
studies only used 
1.5T magnetic field.          
Critical Appraisal 
Tool & Rating: 
John Hopkins 
Research 
Evidence 
Appraisal Tool , III 
A/B.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal: 
Worth to 
Practice
Shenthar, J., 
Milasinovic, G., Al 
Fagih, A., Gotte, 
M., Engel, G., 
Wolff, S., …..Nahle, 
C. (2015). MRI 
scanning in 
patients with new 
and existing 
CapSureFix Novus 
5076 pacemaker 
leads: Randomized 
trial results. Heart 
Rhythm Society , 
12(4), 759-765.
None Randomized 
Control Trial
N = 266; 2:1 ratio 
to the MRI 
group (177 
patients) or to 
the control 
group (89 
patients)
Devices were 
interrogated 
before and after 
MRI.  The MRI 
scan protocol 
was modeled 
after the Advisa 
MRI safety and 
effectiveness 
trial using 1.5-T 
cylindrical
MRI systems7.
Evaluate the 
safety  of
MRI without 
positioning 
restrictions in 
patients with an 
MR conditional
pacemaker and 
currently a 
non–MR-
conditional 
Medtronic
CapSureFix 
Novus 5076 
lead(s).
At 9-12 weeks post 
implant, the MRI 
group underwent MRI 
at 1.5T.  Primary end-
points were MRI-
related complication-
free rate and non-
inferiority of the MRI 
group compared to 
the control group with 
the regard to the 
proportion of patients 
with increase of <0.5V 
in the right atrial  and 
right ventricular 
pacing capture 
thresholds from 
immediately before 
MRI to 1 month post 
MRI.
No MRI-
related 
complications 
occurred in 156 
MRI scanned 
patients who 
were followed 
through 1 
month post 
MRI.  MRI 
scans can be 
performed 
safely. 
Strengths:    
RCT. 
Limitations: 
Data from all 
studies only 
used 1.5T 
magnetic field. 
Critical 
Appraisal Tool 
& Rating:  
John Hopkins 
Research 
Evidence 
Appraisal 
Tool , I A.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:             
Worth to Practice
Shah, A.D., 
Morris, M.A., 
Hirsh, D.S., 
Warnock, M., 
Huang, Y., 
Mollerus, M., 
…..Lloyd,, M.S. 
(2018). 
Magnetic 
resonance 
imaging safety 
in 
nonconditional 
pacemaker and 
defibrillator 
recipients: A 
meta-analysis 
and systematic 
review. Heart 
Rhythm Society , 
1-8.
None Meta-analysis 
and systematic 
review.
Queried indexed 
articles from 
PubMed and 
CINAHL from 
1990-2017. The 
search yielded 
1324 records to 
review.  70 
studies were 
included for the 
systematic 
review. 5099 
patients.
A random effects 
model was used 
for meta-analysis 
of continuous 
variables.  Safety 
outcomes were 
evaluated with 
descriptive 
analysis. 
For the primary 
safety objective, 
a 1-sided, 1-
proportion 
binomial exact 
test was used, and 
the 
corresponding 1-
sided 97.5% 
lower confidence 
bound was 
calculated.
70 studies on 
non-MRI 
conditional 
devices 
undergoing MRI 
were identified, 
allowing 
analysis of 5099 
patients who 
underwent 5908 
MRI studies.  
All lead 
characteristics 
and battery 
voltage showed 
minimal 
changes.  
Electrical resets 
were only found 
in older devices.  
Defibrillator 
function was 
unchanged and 
inappropriate 
were avoided.
This review 
demonstrated low 
lead failure and 
clinical event rates 
in non-MRI 
conditional 
pacemaker and ICD 
undergoing MRI.  
Observed changes 
were small and 
interstudy variance 
was low suggesting 
that the composite 
event rates offer a 
reasonable estimate 
of true effect.  The 
observed adverse 
events reinforce the 
need for ongoing 
monitoring and 
caution.
Strengths:              
Large number of 
studies and significant 
number of patients. 
Limitations:      
Previously published, 
largely observational 
data. Unknown number 
of patients were 
implanted with 
Medtronic model 4076 
and 5076 leads which 
may have lowered the 
clinical risk observed  
because these leads are 
MRI compatible.  The 
data did not allow for 
review of all possible 
device, lead, and MR 
combinations to 
determine safety.  
Critical Appraisal 
Tool & Rating:                
John Hopkins 
Research Evidence 
Appraisal Tool , III 
A/B.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:            
Worth to Practice
Wilkoff, B.L., 
Bello, D., 
Taborsky, M., 
Vymazal, J., 
Kanal, E., 
Heuer, H., 
…..Sommer, T. 
(2011). 
Magnetic 
resonance 
imaging in 
patients with a 
pacemaker 
system 
designed for 
the magnetic 
resonance 
environment. 
Heart Rhythm 
Society , 8, 65-
73.
None Prospective 
Randomized 
Control Trial
N= 464 were 
randomized to 
undergo an MRI 
scan between 9-12 
weeks post 
implant.  MRI 
group n = 258 or 
not undergo an 
MRI (control 
group n = 206) 
after successful 
implantation of 
specially 
designed dual 
chamber 
pacemaker and 
leads.
Pacemaker 
performance, 
pacing capture 
threshold, 
evaluation 9-12 
weeks prior to 
MRI, during MRI, 
and immediately 
after MRI.  
Technical 
observations and 
adverse events 
were evaluated.
Sequences were 
performed at 
1.5T and 
included scans 
with high 
radiofrequency 
power 
deposition 
and/or high 
gradient dB/dt 
exposure.
Patients were 
monitored for 
arrhythmias, 
symptoms, and 
pacemaker system 
function during 14 
non-clinically 
indicated relevant 
brain and lumbar 
MRI sequences.
No MRI related 
complications 
occurred during 
or after the MRI.
Strengths:              
This trial documented 
the ability of the 
pacemaker to be 
exposed in a 
controlled fashion to 
MRI in a 1.5T scanner 
without adverse 
impact on patient 
outcomes or 
pacemaker function. 
Limitations:           
Data only from 1.5T 
magnetic field.  Use of 
MRI scanners on 
pacemaker patients 
was specifically 
limited to well-defined 
conditions in the trial 
and safe use outside 
of these conditions 
was not demonstrated.  
Critical Appraisal 
Tool & Rating:       
John Hopkins 
Research Evidence 
Appraisal Tool , I A.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:      
Worth to Practice
Bailey, W.M., 
Mazur, A., 
McCotter, C., 
Woodard, P.K., 
Rosenthal, L., 
Johnson, W., & 
Mela, T. (2016). 
Clinical safety of 
the ProMRI 
pacemaker 
system in patients 
subjected to 
thoracic spine and 
cardiac 1.5T 
magnetic 
resonance 
imaging scanning 
conditions. 
Heart Rhythm 
Society , 13, 464-
471.
None Prospective 
Single, Non-
randomized study
N = 245 with 
stable baseline 
pacing indices 
implanted with a 
Biotronik Entovis 
pacemaker and 
Sertox leads.
Pre-MRI, atrial and 
ventricular sensing 
and thresholds.  
Using 
investigational 
software.
Device interrogation 
was performed at 
enrollment, pre and 
post MRI scan, and 1 
and 3 months post 
MRI.  
216 patients 
completed the MRI 
and 1-month post-
MRI follow up.  
Statistical analysis 
was based on the 
proportion of the 
leads or patients 
satisfying end-point 
criteria. Two-sided 
95% CIs for the 
parameters were 
given.
One adverse 
event possibly 
related to the 
implanted 
system and the 
MRI procedure 
occurred, 
adverse device 
effect-free rate 
of 99.6%.  The 
study 
demonstrated 
the clinical 
safety and 
efficacy of the 
ProMRI 
pacemaker 
system. 
Strengths:          
This study 
demonstrated the 
safety and function 
of the ProMRI 
pacemaker. 
Limitations:   
Sample size was 
insufficient to 
observe rare 
adverse effects of 
MRI on the patient 
population.  The 
number of cardiac 
MRI was lower than 
thoracic MRI and 
could 
underestimate the 
risk of cardiac 
MRI.               
Critical Appraisal 
Tool & Rating:  
John Hopkins 
Research Evidence 
Appraisal Tool , II 
A.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:               
Worth to Practice
Nazarian, S., 
Hansford, R., 
Rahsepar, A.A., 
Weltin,V., 
McVeigh, D., 
Ipek, E.G.,….. 
Halperin, H.R. 
(2017). Safety of 
magnetic 
resonance 
imaging in 
patients with 
cardiac devices. 
The New 
England 
Journal of 
Medicin e, 
377(26), 2555-
2564.
None Prospective, 
Single, Non-
randomized study
N = 1509 who 
underwent 2103 
thoracic and non-
thoracic MRIs
Evaluated the 
safety of MRI, 
performed with 
the use of a 
prespecified 
safety protocol.  
Lead parameters
were compared 
with the use of 
the Wilcoxon
signed-rank test, 
with MRI 
examination
as the unit of 
analysis.
The pacing mode 
was changed to 
asynchronous 
mode for pacing 
dependent 
patients and to 
demand mode for 
other patients.
In 9 MRI exams, 
95% CI was 
reported. The 
most common 
notable change 
in device 
parameters 
immediately after 
MRI was a 
decrease in the P 
wave amplitude, 
which occurred 
in 1% of the 
patients.  Lead 
parameters were 
compared with 
the use of the 
Wilcoxon signed 
rank test with 
MRI examination 
as the unit of 
analysis.
Lead 
parameters were 
compared with 
the use of the 
Wilcoxon 
signed rank test 
with MRI 
examination as 
the unit of 
analysis.
Strengths:                      
This study 
demonstrated the MRI 
safety of pacemakers 
and ICDs.     
Limitations:                   
Data was acquired at a 
single center and may 
not be generalizable to 
other clinical settings 
and MRI facilities.  
Unable to obtain long-
term follow up 
information from 302 
patients.  The study did 
not perform 
defibrillation testing in 
patients who had an 
ICD. The numbers of 
each individual devices 
were small.  Interactions 
of future systems 
cannot be ruled out. 
Critical Appraisal Tool 
& Rating:
John Hopkins Research 
Evidence Appraisal 
Tool ,  II A.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:          
Worth to Practice
Van der Graaf, 
A.W.M., Bhagirath, 
P., & Gotte, M.J.W. 
(2014). MRI and 
cardiac implantable 
electronic devices; 
current status and 
required safety 
conditions. 
Netherlands Heart 
Journal , 22, 269-
276. Retrieved from 
http://dx.doi.org/10.
1007/s12471-014-
0544-x
None Abstract This review paper 
provides an 
overview of the 
currently 
available data 
related to CIEDs 
and MRI and 
attempts to offer 
an up-to date and 
clinically useful 
summary for the 
practicing 
cardiologist. Six 
studies and four 
clinical trials were 
reviewed.
6 studies and 4 
clinical trials were 
reviewed.
Reviewed clinical 
trials and 
numerous 
literature to 
study the safety 
of MRIs and 
CIEDs.
An overview of 
all available MRI 
conditional 
devices and their 
individual 
restrictions was 
given.
With 
appropriate 
monitoring 
and 
application
of a safety 
protocol, MRI 
can be safely 
performed in
patients with 
CIEDs.
Strengths:              
This abstract 
demonstrated the 
MRI safety of 
pacemakers and 
ICDs.               
Limitations:           
Data was limited to 
the 6 studies and 
4clinical trials.  
Studies with use of 
higher magnetic 
strength should have 
been included.  
Critical Appraisal 
Tool & Rating:      
John Hopkins 
Research Evidence 
Appraisal Tool , III 
A/B.
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Citation Conceptual 
Framework
Design/Method Sample/Setting Variable Studied 
and Their 
Definitions
Measurement Data Analysis Findings Appraisal:      
Worth to Practice
Nordbeck, P., 
Ertl, G., & 
Ritter, O. 
(2015). 
Magnetic 
resonance 
imaging safety 
in pacemaker 
and 
implantable 
cardioverter 
defibrillator 
patients: How 
far have we 
come? 
European 
Heart 
Journa l, 36, 
1501-1511.
None Clinical Review 
and Update
This clinical 
review provides a 
better 
understanding of 
the mechanisms 
responsible for 
life-threatening 
complications as 
well as technical 
advances 
allowing an 
increasing 
number of 
pacemakers and 
ICDs to safely 
undergo MRIs.
Reviewed clinical 
trials over the last 
20 years.
14 pacemaker 
studies and 13 
ICD studies. 
14 pacemaker 
studies and 13 
ICD studies 
assessed the 
outcome in 1.5T 
MR scanners.  
There were no 
adverse events 
reported. 
Appropriate 
monitoring and 
application
of a safety 
protocol, MRIs 
can be safely 
performed in
patients with 
CIEDs.
Strengths:        
This review 
demonstrated the 
MRI safety of 
pacemakers and 
ICDs.   
Limitations:      
Data was limited to 
14 pacemaker 
studies and 13 ICD 
studies.  Studies 
with use of higher 
magnetic strength 
(>1.5T) should 
have been 
included.     
Critical Appraisal 
Tool & Rating:
John Hopkins 
Research 
Evidence 
Appraisal Tool , III 
A/B.
